Feature|Videos|May 28, 2024
A Different CDMO Experience: Q&A With Scorpius’ President & COO Joe Payne
Author(s)Scorpius BioManufacturing
Joe Payne, Scorpius BioManufacturing, comments on the unique needs of today's biopharmaceutical companies looking to develop and manufacture small-volume, early-stage large molecules.
Watch the video and learn more:
- Learn about Scorpius’ president and COO, Joe Payne, as a thought leader who is also approachable, energetic, and in-tune with client needs.
- Learn about Scorpius’ competitive advantages in biomanufacturing of small-volume, early-stage large molecules.
- Learn what it takes to produce an end product that can be shared with both prospective clients and prospective employees.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
2
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
3
Pharmapack Europe 2026: Sustainability, Specialization, and Digitalization in Packaging
4
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
5